American Association for Cancer Research, April 27-28
The American Association for Cancer Research Annual Meeting 2020 The annual meeting of the American Association for Cancer Research was held virtually this...
Patients With Cancer Seem More Vulnerable to COVID-19
Frequency of severe events highest for patients with hematologic cancer, lung cancer, and metastatic cancer
Impact of COVID-19 on Oncology Clinical Trials Discussed
Recommendations for sustaining cancer care access include permanent expanded support for telehealth
April 2020 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for April 2020. This roundup includes...
COVID-19 Case Fatality Rate Increased for Cancer Patients
Case fatality rates were 37 and 25 percent for hematologic and solid malignancies, respectively
Medicaid Expansion Tied to Higher Mammography Rates
Expansion states saw higher Medicaid, total insurance coverage, and use of coverage for mammography
Symptomatic Health Care Staff in U.K. Screened for COVID-19
Shift in transmission dynamics noted as of March 24, concurrent with steps to implement social distancing
PFS Prolonged With Continuous Dabrafenib, Trametinib in Melanoma
Median PFS longer with continuous versus intermittent treatment, but overall survival similar
Thromboembolic Complications in COVID-19 Discussed
All hospitalized COVID-19 patients should be started on prophylactic low-molecular-weight heparin
Multicancer Blood Test, PET-CT Combo Feasible for Cancer Screen
One percent of participants underwent PET-CT imaging due to false-positive blood tests
